Jury Hands Down a Verdict in Prevagen Deceptive Marketing Case
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
In May 2020, a class-action lawsuit was filed against Global Institute of Stem Cell Therapy and Research for allegedly:
Plaintiffs also claim that the defendants are not licensed to perform stem cell treatments in the United States. (Mendez et al v. Global Institute of Stem Cell Therapy and Research USA et al, Case No. 20-cv-915, S.D. Cal.)
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
Grab your bag now, before Dina & Mita do
Regulators have a beef with company’s climate pledge.
Consumers need to be wary of undisclosed incentivized reviews.
Why TINA.org supports FTC’s proposed changes to COPPA Rule but pushes for more.